Mosanna Therapeutics

Pioneering a pharmaceutical nasal spray to restore natural airway control for sleep apnea.

Redwood City, United States · Founded 2022 · $80.0M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$80.0M
Last Round
$80.0M Series AJun 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mosanna Therapeutics is a clinical-stage biotech company developing a novel pharmaceutical approach to treating obstructive sleep apnea (OSA), which affects an estimated 1 billion people globally. Its lead therapy, MOS118, is an easy-to-use nighttime nasal spray designed to restore the body's natural upper airway reflex during sleep — treating OSA as a neurological and muscular dysfunction rather than a purely mechanical problem. This positions MOS118 as a non-invasive alternative to CPAP and other mechanical treatments. The $80 million Series A was led by Pivotal bioVenture Partners and EQT Life Sciences, with co-leads Forbion, Broadview Ventures, and Norwest. MOS118 is currently in Phase 1 clinical trials, with the new funding advancing it through Phase 2. Mosanna has offices in Redwood City, California and Basel, Switzerland.

Summary

Mosanna Therapeutics is a Biotech company based in Redwood City, United States, founded in 2022. It has raised $80.0M in total across 3 rounds, most recently a $80.0M Series A round in Jun 2025. Investors include Pivotal bioVenture Partners, Forbion Capital Partners and Broadview Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2025
$80.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mosanna Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mosanna-therapeutics"><img src="https://indexed.vc/api/badge/company/mosanna-therapeutics" alt="Mosanna Therapeutics on Indexed.vc" width="260" height="76" /></a>